Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
1.135
+0.045 (4.13%)
Mar 28, 2024, 2:00 PM EDT - Market open
Bionano Genomics Stock Forecast
BNGO's stock price has decreased by -89.01% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bionano Genomics stock have an average target of 8.00, with a low estimate of 6.00 and a high estimate of 10. The average target predicts an increase of 604.85% from the current stock price of 1.14.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for BNGO stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Hold | 0 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +428.63% | Mar 7, 2024 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 13, 2023 |
BTIG | BTIG | Strong Buy Maintains $2 → $10 | Strong Buy | Maintains | $2 → $10 | +781.06% | Aug 10, 2023 |
BTIG | BTIG | Strong Buy Maintains $30 → $20 | Strong Buy | Maintains | $30 → $20 | +1,662.11% | May 18, 2023 |
BTIG | BTIG | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +2,543.17% | Apr 24, 2023 |
Financial Forecast
Revenue This Year
48.11M
from 36.12M
Increased by 33.22%
Revenue Next Year
66.18M
from 48.11M
Increased by 37.55%
EPS This Year
-2.54
from -6.81
EPS Next Year
-1.66
from -2.54
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 52.5M | 71.9M | 119.1M | 170.9M | 245.8M |
Avg | 48.1M | 66.2M | 115.6M | 166.0M | 238.8M |
Low | 44.1M | 60.0M | 111.1M | 159.5M | 229.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 45.4% | 49.4% | 79.9% | 47.7% | 48.1% |
Avg | 33.2% | 37.6% | 74.7% | 43.5% | 43.9% |
Low | 22.1% | 24.6% | 67.9% | 37.9% | 38.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.59 | -0.75 | -0.42 | -0.14 | 0.20 |
Avg | -2.54 | -1.66 | -0.41 | -0.13 | 0.19 |
Low | -3.02 | -2.30 | -0.39 | -0.13 | 0.19 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.